Aldeyra Therapeutics, Inc. (ALDX)
↓ Download CSVKey ratios (FY2025)
-76.5%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Income | -$35.27M | -$60.12M | -$42.79M | -$62.68M | -$56.22M | -$36.42M | -$63.07M | -$39.70M | -$22.49M | -$18.70M |
| Net Income | -$33.85M | -$55.85M | -$37.54M | -$62.02M | -$57.78M | -$37.55M | -$60.83M | -$38.89M | -$22.34M | -$18.70M |
| EPS (Diluted) | $-0.56 | $-0.94 | $-0.64 | $-1.06 | $-1.07 | — | — | — | — | — |
| Total Assets | $72.06M | $104.61M | $148.33M | $181.29M | $233.14M | $83.35M | $75.52M | $95.09M | $44.17M | $25.19M |
| Total Liabilities | $27.81M | $33.60M | $28.53M | $30.28M | $27.40M | $23.84M | $27.44M | $8.47M | $4.57M | $3.54M |
| Shareholders' Equity | $44.25M | $71.00M | $119.80M | $151.01M | $205.74M | $59.51M | $48.08M | $86.62M | $39.60M | $21.65M |
| Cash & Equivalents | $70.04M | $54.53M | — | $144.42M | $229.79M | $77.86M | $44.43M | $47.36M | $20.02M | $12.02M |
| Operating Cash Flow | -$33.35M | -$43.21M | -$30.33M | -$56.64M | -$42.56M | -$37.49M | -$44.98M | -$29.86M | -$19.22M | — |
| Capital Expenditures | — | — | $0 | $16.3K | $7.8K | — | $9.5K | $263.0K | $24.8K | $11.8K |
| Shares Outstanding | 60.16M | 59.65M | 59.20M | 58.56M | 58.08M | 38.67M | 28.66M | 26.24M | 19.14M | 12.58M |